PLUS THERAPEUTICS, Inc. Common Stock — チャート、価格、ニュース (NASDAQ:PSTV)

チャート全体を表示 Full chart

Financials

概要明細書統計

期次年次

Market Capitalization 40.82 M
Employee 28
Founded 1996
CEO N/A
Website www.plustherapeutics.com
Headquarter Delaware, United States
FIGI BBG000C1Z086
Industry 生物工学

総売上高

当期純利益

1株当たり基本利益（基本EPS）

有利子負債合計

フリーキャッシュフロー

現金および現金同等物

株価収益率

-1.77

売上高対価格比率

7.65

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.